In a PD mouse model, the specific knockout of Drd2 in CD4+ T cells resulted in increased dopamine neurotoxicity, motor impairment, microglial activation, and the polarization of CD4+ T cells toward the Th1 and Th17 phenotypes (Liu et al., 2021). Here, CD4 is linked to Parkinson disease.